Quest Diagnostics Shares Outstanding 2006-2018 | DGX

Quest Diagnostics shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Quest Diagnostics shares outstanding for the quarter ending September 30, 2018 were 0.139B, a 0.71% decline year-over-year.
  • Quest Diagnostics 2017 shares outstanding were 0.14B, a 1.41% decline from 2016.
  • Quest Diagnostics 2016 shares outstanding were 0.142B, a 2.07% decline from 2015.
  • Quest Diagnostics 2015 shares outstanding were 0.145B, a 0% decline from 2014.
Quest Diagnostics Annual Shares Outstanding
(Millions of Shares)
2017 140
2016 142
2015 145
2014 145
2013 153
2012 160
2011 160
2010 177
2009 188
2008 196
2007 195
2006 200
2005 206
Quest Diagnostics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 139
Q2 2018 139
Q1 2018 139
Q4 2017 140
Q3 2017 140
Q2 2017 140
Q1 2017 141
Q4 2016 142
Q3 2016 142
Q2 2016 142
Q1 2016 144
Q4 2015 145
Q3 2015 145
Q2 2015 145
Q1 2015 146
Q4 2014 145
Q3 2014 145
Q2 2014 145
Q1 2014 145
Q4 2013 153
Q3 2013 151
Q2 2013 154
Q1 2013 159
Q4 2012 160
Q3 2012 161
Q2 2012 160
Q1 2012 160
Q4 2011 160
Q3 2011 159
Q2 2011 159
Q1 2011 161
Q4 2010 177
Q3 2010 174
Q2 2010 181
Q1 2010 182
Q4 2009 188
Q3 2009 187
Q2 2009 187
Q1 2009 191
Q4 2008 196
Q3 2008 197
Q2 2008 196
Q1 2008 196
Q4 2007 195
Q3 2007 196
Q2 2007 194
Q1 2007 195
Q4 2006 200
Q3 2006 200
Q2 2006 201
Q1 2006 201
Q4 2005 206
Q3 2005 206
Q2 2005 207
Q1 2005 206
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.887B $7.709B
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Stock Name Country Market Cap PE Ratio
Elanco Animal Health (ELAN) United States $12.435B 0.00
DaVita (DVA) United States $10.682B 17.98
Encompass Health (EHC) United States $7.065B 20.23
Chemed (CHE) United States $4.918B 27.04
Amedisys (AMED) United States $3.734B 35.49
LHC Group (LHCG) United States $2.922B 30.63
U.S Physical Therapy (USPH) United States $1.460B 47.54
Addus HomeCare (ADUS) United States $0.894B 42.15
Hanger (HNGR) United States $0.689B 6.95
RadNet (RDNT) United States $0.636B 40.69
American Renal Associates Holdings (ARA) United States $0.506B 22.88
BioScrip (BIOS) United States $0.405B 0.00
Quorum Health (QHC) United States $0.154B 0.00
Catasys (CATS) United States $0.150B 0.00
Psychemedics (PMD) United States $0.101B 20.53
AAC Holdings (AAC) United States $0.057B 9.71
Daxor (DXR) United States $0.028B 0.00
Helios And Matheson Analytics Inc (HMNY) United States $0.011B 0.00